ADCT
ADC Therapeutics
ADC Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Company Sector
5 companies tagged with ADCs.
ADCs, or antibody-drug conjugates, combine the targeting ability of antibodies with the payload of a cytotoxic drug. This sector page groups companies working on ADC platforms or lead ADC assets, especially in oncology where the modality has become increasingly important.
ADCT
ADC Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
AMAM
Ambrx Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
IMGN
ImmunoGen is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
STRO
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
VINC
Vincerx Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.